ftInvstr
RPGLIFE · Healthcare ₹2720.2 +2.3% Mkt Cap ₹4517 Cr

RPGLIFE

Healthcare Drug Manufacturers - Specialty & Generic
₹2720.2
+2.3% today · 30d +2.26%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for RPGLIFE. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹196 Cr
+15.85% YoY
NET PROFIT
₹31 Cr
+17.0% YoY
OPM
23.95%
+0.58pp YoY
EPS
₹18.6
PE 37.58
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-0.2% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
RPGLIFE37.58
SUNPHARMA37.5721.44
DIVISLAB89.1821.56
ZYDUSLIFE24.6424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
62
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 75
Valuation FAIR 40
Growth MUTED 31
Profitability HIGH 75
Technicals STRONG 70
Risk LOW 80
Key Stats
TTM PE
37.58
P/B
7.43
52W HIGH
₹3082.0
OFF HIGH
-11.74%
DIV YIELD
0.88%
MKT CAP
₹4517 Cr
◉ Active Signals
MACDNeutral4.2539
RSI(14)Neutral54.94
Street Consensus
1 analyst
₹3340.0
mean target
Low ₹3340.0Now ₹2720.2High ₹3340.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold RPGLIFE and at what entry.

Sign up freeSign in